PAHC
Phibro Animal Health Corp
Phibro Animal Health Corp historical holders
total: 2
Polen Capital Management Phibro Animal Health Corp transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Polen Capital Management has been an institutional investor in Phibro Animal Health Corp (PAHC) since 2026 Q1. According to 2026 Q2 report, Polen Capital Management doesn't hold any shares. The fund/company first acquired PAHC in 2026 Q1, initially purchasing 6,775 shares. Since the initial investment, Polen Capital Management has made 1 more transaction in this position.
When did Polen Capital Management exit their PAHC position?
Polen Capital Management no longer holds Phibro Animal Health Corp (PAHC). They sold off their entire position in 2026 Q2, closing out an investment that began in 2026 Q1.
When did Polen Capital Management first invest in PAHC?
Polen Capital Management first invested in Phibro Animal Health Corp (PAHC) in 2026 Q1 at the reported quarter-end price of $55.31 per share, acquiring 6,775 shares in their initial purchase.
What is Polen Capital Management's average cost basis for PAHC?
Based on historical transaction data, Polen Capital Management's estimated cost basis for Phibro Animal Health Corp (PAHC) is approximately $55.31 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $55.31
- Weighted AVG sell price:
- $55.31
PAHC transactions history by Polen Capital Management
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
0
|
$55.31
|
|
-100% (-6,775)
|
-0%
|
|
2026 Q1
|
0.00%
|
6,775
|
$55.31
|
$374,725
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.